Tenet Healthcare Corporation $THC Shares Purchased by Sirios Capital Management L P

Sirios Capital Management L P lifted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 100.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 71,566 shares of the company’s stock after buying an additional 35,947 shares during the period. Tenet Healthcare makes up approximately 1.9% of Sirios Capital Management L P’s portfolio, making the stock its 18th largest position. Sirios Capital Management L P’s holdings in Tenet Healthcare were worth $14,531,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare during the third quarter worth $32,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. Westside Investment Management Inc. grew its holdings in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the period. Trust Co. of Vermont acquired a new stake in shares of Tenet Healthcare during the 3rd quarter worth about $41,000. Finally, Geneos Wealth Management Inc. lifted its position in Tenet Healthcare by 50.9% in the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after buying an additional 89 shares during the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Trading Up 1.4%

THC opened at $227.79 on Friday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21. The company has a market cap of $19.81 billion, a P/E ratio of 14.71, a PEG ratio of 1.11 and a beta of 1.39. The business’s 50-day simple moving average is $213.46 and its 200-day simple moving average is $203.99.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analyst Ratings Changes

THC has been the subject of a number of recent analyst reports. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Guggenheim increased their price target on Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a report on Monday, February 16th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Insider Activity at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president owned 8,012 shares in the company, valued at $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 48,695 shares of company stock worth $11,373,201. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.